Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

A new compound effectively inhibits human 5α-reductase 1.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

A new compound that could treat various androgen-related conditions was created and analyzed.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The compound 4c effectively inhibits the enzyme linked to hair loss.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The new compound may be a safer alternative to finasteride for prostate protection.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.